Judith Raber - Durlacher

PhD

1983 …2024

Research activity per year

Network

Anne Marie Westermann

Person: Academic

Juliette Stolze

Person: Academic

W.M.H. Rademacher

Person: Academic

Nicole M. A. Blijlevens

  • Radboud University Nijmegen

External person

I. von Bültzingslöwen

  • University of Gothenburg

External person

M. T. Brennan

  • Carolinas Medical Center

External person

Renske Z. Thomas

  • Radboud University Medical Center

External person

O. Nicolatou-Galitis

  • National and Kapodistrian University of Athens

External person

Alan Henry Brook

  • University of Adelaide
  • Queen Mary University of London

External person

Marjolein S. Bulthuis

  • Radboud University Medical Center

External person

Lucky L. A. van Gennip

  • Radboud University Medical Center

External person

Salvatore Grisanti

  • Klinik für Augenheilkunde

External person

J.B. Epstein

  • Cedars-Sinai Health Center
  • City of Hope National Med Center
  • Cedars-Sinai Medical Center
  • Seattle Cancer Care Alliance

External person

W.C. Chie

  • National Taiwan University

External person

J. Lodewijckx

  • Faculty of Medicine and Life Sciences

External person

Scott Isom

  • Wake Forest University

External person

Catherine Hong

  • National University of Singapore

External person

S. Singer

  • Johannes Gutenberg University Mainz

External person

Jenny Öhman

  • University of Gothenburg

External person

Andrica C.H. de Vries

  • Erasmus Medical Center
  • Princess Maxima Centre for Pediatric Oncology
  • Erasmus Universiteit Rotterdam
  • Princess Máxima Center for Pediatric Oncology

External person

J.B. Epstein

  • City of Hope National Med Center
  • Cedars-Sinai Medical Center

External person

V. Grégoire

  • Université Catholique de Louvain and St-Luc University Hospital

External person

A. Boehm

  • St. Georg Hospital

External person

R. Galalae

  • University of Duisburg-Essen

External person

Wim J. Tissing

  • Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, Netherlands
  • Department of Pediatric Oncology/Hematology, Groningen, Netherlands

External person

Margriet Van Der Heiden-Van Der Loo

  • Dutch Childhood Oncology Group
  • Comprehensive Cancer Centre Middle Netherlands

External person

H. Mehanna

  • University of Birmingham

External person

P. Zotti

  • Centro di Riferimento Oncologico di Aviano (CRO) IRCCS

External person

Juan I Arraras

  • Complejo Hospitalario de Navarra

External person

N. Yarom

  • Tel Aviv University

External person

Nasser Nadjmi

  • University of Antwerp

External person

Z. Abdel-Hafeez

  • Ain Shams University

External person

P. Bonomo

  • Azienda Ospedaliero Universitaria Careggi

External person

Sebastian JCMM Neggers

  • Princess Máxima Center for Pediatric Oncology
  • Erasmus Universiteit Rotterdam

External person

David M. Kline

  • Wake Forest University

External person

I. Baumann

  • Heidelberg University

External person

Philip J. Turk

  • University of Mississippi

External person

K. Bjordal

  • Oslo University Hospital

External person

C. Brannan

  • East & North Hertfordshire NHS Trust incorporating Mount Vernon Cancer Centre

External person

L. Fernandez Gonzalez

  • Instituto Oncológico Fundación Arturo López Pérez

External person

Dorine Bresters

  • Leiden University Medical Centre
  • Leiden University
  • Free University Hospital
  • Vrije Universiteit Amsterdam
  • Princess Máxima Center for Pediatric Oncology

External person

R.G. Nair

  • Griffith University Queensland

External person

A.C. Sherman

  • University of Arkansas for Medical Sciences

External person

C.D. Amdal

  • Oslo University Hospital

External person

C. Schmalz

  • Campus Kiel

External person

G. B. Proctor

  • King's College London

External person

C. Migliorati

  • University of Florida

External person

I.M. Tomaszewska

  • Jagiellonian University Medical College

External person

A. Barasch

  • Harvard University

External person

M.-T. Genot-Klastersky

  • Université libre de Bruxelles

External person

Olaf van Tellingen

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

G. Dimitriadis

  • University of Southampton

External person

Anura Ariyawardana

  • James Cook University Queensland

External person

B. Brokstad Herlofson

  • University of Oslo

External person

N. Treister

  • Harvard University

External person

A. Staes

  • VIB Center for Medical Biotechnology
  • Ghent University

External person

Susanne Singer

  • Johannes Gutenberg University Mainz

External person

J. Castro Silva

  • Instituto Portugues de Oncologia de Francisco Gentil Porto

External person

L. Licitra

  • Università degli Studi di Milano
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

External person

Hieu M. Nguyen

  • Center for Outcomes Research and Evaluation

External person

Marlou Boor

  • Vrije Universiteit Amsterdam

External person

M. Louwerens

  • Leiden University

External person

C. M. J. Potting

  • Radboud University Medical Center

External person

J. Inhestern

  • Friedrich Schiller University Jena

External person

M. Pinto

  • Istituto Nazionale Tumori –IRCCS- Fondazione G. Pascale

External person

Marry M. van den Heuvel-Eibrink

  • Erasmus Universiteit Rotterdam
  • Princess M?xima Center for Pedriatric Oncology
  • University Medical Center Utrecht
  • Catharina Hospital
  • Utrecht University
  • Erasmus MC
  • Erasmus Medical Center
  • Princes Maxima Center for Pediatric Oncology
  • Erasmus MC – Sophia Children's Hospital
  • Princess Maxima Center for Pediatric Oncology
  • Dutch Childhood Oncology Group (DCOG)
  • Princess Maxima Centre for Pediatric Oncology
  • Princess Máxima Center for Pediatric Oncology
  • Princess Maxima Center for Pediatric Oncology
  • Princess Máxima Center for Pediatric Oncology

External person

E. Hammerlid

  • Sahlgrenska University Hospital

External person

D. Hofmeister

  • Leipzig University Medical Center

External person

B. A. B. Versluys

  • Princess M?xima Center for Pedriatric Oncology
  • Utrecht University

External person

A. Fullerton

  • University of Florida

External person

Jaqueline J. Loonen

  • Radboud University Nijmegen

External person

M. Santos

  • University of Brasília

External person

Kristina Skallsjö

  • University of Gothenburg

External person

S. Loo

  • Maudsley NHS Foundation Trust, King's College London

External person

Wim J. E. Tissing

  • Princess Máxima Center for Pediatric Oncology
  • University of Groningen

External person

G. ran Dahllöf

  • Karolinska Institutet

External person

E. M. Bronkhorst

  • Radboud University Medical Center

External person

J. Robijns

  • Faculty of Medicine and Life Sciences

External person

D. Bresters

  • Leiden University

External person

Heidi M. Whiteside

  • Wake Forest University

External person

S. Krejovic Trivic

  • University of Belgrade

External person

R.J. Bensadoun

  • Centre de Haute Energie

External person

H. Behrendt

  • Amsterdam UMC - Vrije Universiteit Amsterdam

External person

N. Kiyota

  • Kobe University Hospital Cancer Center

External person

P. Arany

  • SUNY Buffalo

External person